Literature DB >> 28507457

Evaluating the performance of TG-43 protocol in esophageal HDR brachytherapy viewpoint to trachea inhomogeneity.

Seyed Mohsen Hosseini Daghigh1, Hamid Reza Baghani1, Seyed Mahmoud Reza Aghamiri1, Seyed Rabi Mahdavi2.   

Abstract

AIM: The aim of this study is to evaluate the effect of air within trachea on dose calculations of esophageal HDR brachytherapy treatment planning.
BACKGROUND: Dose calculations in esophageal HDR brachytherapy treatment planning systems are greatly based on TG-43 protocol which in all materials are considered to be water equivalent.
MATERIALS AND METHODS: A cylindrical PMMA phantom with a tube in the center (neck equivalent phantom) accompanied by Flexitron HDR brachytherapy system was used in this study. Brachytherapy applicators with various diameters were placed inside the esophageal tube and EDR2 film was used for dosimetry. The absorbed dose by reference point of esophageal HDR brachytherapy and anterior wall of trachea were measured and compared with those calculated by Flexiplan treatment planning system.
RESULTS: Based on the performed statistical analysis (t-test) with 95% confidence level (t-value >1.96), there was a meaningful difference between the results of film dosimetry and treatment planning at all of the points understudy.
CONCLUSION: The meaningful difference between the results of film dosimetry and treatment planning indicates that the trachea inhomogeneity has a considerable effect on dose calculations of Flexiplan treatment planning software featuring the TG-43 dose calculation algorithm. This mismatch can affect the accuracy of performed treatment plan and irradiation.

Entities:  

Keywords:  Esophageal HDR brachytherapy; Film dosimetry; TG-43 protocol; Trachea inhomogeneity; Treatment planning

Year:  2017        PMID: 28507457      PMCID: PMC5422020          DOI: 10.1016/j.rpor.2017.04.001

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  17 in total

1.  The effect of patient inhomogeneities in oesophageal 192Ir HDR brachytherapy: a Monte Carlo and analytical dosimetry study.

Authors:  G Anagnostopoulos; D Baltas; E Pantelis; P Papagiannis; L Sakelliou
Journal:  Phys Med Biol       Date:  2004-06-21       Impact factor: 3.609

2.  Palliative treatment by high-dose-rate intraluminal brachytherapy in patients with advanced esophageal cancer.

Authors:  Janusz Skowronek; Tomasz Piotrowski; Grzegorz Zwierzchowski
Journal:  Brachytherapy       Date:  2004       Impact factor: 2.362

3.  The water equivalence of solid phantoms for low energy photon beams.

Authors:  Robin Hill; Zdenka Kuncic; Clive Baldock
Journal:  Med Phys       Date:  2010-08       Impact factor: 4.071

4.  TG-69: radiographic film for megavoltage beam dosimetry.

Authors:  Sujatha Pai; Indra J Das; James F Dempsey; Kwok L Lam; Thomas J Losasso; Arthur J Olch; Jatinder R Palta; Lawrence E Reinstein; Dan Ritt; Ellen E Wilcox
Journal:  Med Phys       Date:  2007-06       Impact factor: 4.071

5.  A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.

Authors:  Emily Poon; Frank Verhaegen
Journal:  Med Phys       Date:  2009-09       Impact factor: 4.071

6.  Calibration of (192)Ir high dose rate brachytherapy source using different calibration procedures.

Authors:  Shwetha Bondel; Manickham Ravikumar; Sanjay Sudhakar Supe; Buchuppudi Rekha Reddy
Journal:  Rep Pract Oncol Radiother       Date:  2013-08-23

7.  Tissue composition effect on dose distribution in neutron brachytherapy/neutron capture therapy.

Authors:  Mohsen Khosroabadi; Bagher Farhood; Mahdi Ghorbani; Nima Hamzian; Homa Rezaei Moghaddam; David Davenport
Journal:  Rep Pract Oncol Radiother       Date:  2015-06-10

8.  Study of the dosimetric differences between (192)Ir and (60)Co sources of high dose rate brachytherapy for breast interstitial implant.

Authors:  Mourougan Sinnatamby; Vivekanandan Nagarajan; Reddy Kanipakam Sathyanarayana; Gunaseelan Karunanidhi; Vivekanandam Singhavajala
Journal:  Rep Pract Oncol Radiother       Date:  2016-05-11

9.  Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency.

Authors:  Eduardo Rosenblatt; Glenn Jones; Ranjan K Sur; Bernard Donde; Joao V Salvajoli; Sarbani Ghosh-Laskar; Ana Frobe; Ahmed Suleiman; Zefen Xiao; Subir Nag
Journal:  Radiother Oncol       Date:  2010-10-13       Impact factor: 6.280

Review 10.  Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy.

Authors:  Vinay Sharma; Umesh Mahantshetty; Ketayun A Dinshaw; Raman Deshpande; Sanjay Sharma
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.